Abstract A 22-year-old woman was diagnosed with intermediate risk stage II Hodgkin lymphoma and treated with three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by involved-field radiation therapy. A complete metabolic remission was achieved after two cycles of ABVD, which was maintained until three years after completion of treatment. Follow-up FDG-PET/CT four years after completion of treatment, however, showed a new FDG-avid (Deauville score of 4) lesion in the right scapula, suggesting relapsed disease. Computer tomography (CT)-guided biopsy of this lesion was performed and subsequent histological examination revealed a radiation-induced giant cell granuloma.
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Ethical Statement The study was approved by an institutional review board or equivalent and has been performed in accordance with the (Figure part K) . In addition, CD30 and CD15 were negative (not shown). Therefore, relapsed Hodgkin lymphoma was excluded. The spindled cells and the lack of mutation H3F3A are unusual for a giant cell tumor of bone. The lack of atypia and mitoses as well as its size at imaging make an osteosarcoma also less plausible. A giant cell process as seen in a brown tumor in hyperparathyroidism was excluded biochemically (parathyroid hormone 1,9 pmol/L [normal range: 0,5-4,2 pmol/L]). Considering the exposure of the right scapula to the radiation therapy, a reactive process, such as a giant cell granuloma would be the most likely diagnosis [1] , although the giant cells are not typically clustered and rather large. In conclusion, this case demonstrates the non-specificity of FDG-PET/CT in the follow-up setting of Hodgkin lymphoma, the need for biopsy of suspicious FDG-avid lesions before a change in treatment planning can be justified, and that a rare reactive process such as a (probably) radiation-induced giant cell granuloma can mimic relapsed Hodgkin lymphoma ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All subjects in the study gave written informed consent or the institutional review board waived the need to obtain informed consent.
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